Klarna Group plc Chief Commercial Officer David Sykes filed a Form 4 on October 30, 2026, disclosing two non-derivative share transactions and two option grants occurring between July 30, 2026, and September 28, 2026.

Key Highlights

  • July 30 conversion: Sykes acquired 541 ordinary shares on July 30, 2026, via transaction code M, bringing his direct holdings to 181,941 shares.
  • September 28 award: Sykes acquired an additional 65,457 ordinary shares on September 28, 2026, via transaction code A, raising his direct holdings to 247,398 shares.
  • Option grant at $14: On August 20, 2026, Sykes was awarded 341,917 options with an exercise price of $14, exercisable from August 20, 2027, through February 20, 2031; his resulting holdings in this option class stand at 1,767,601.
  • Option grant at $42: On the same date, Sykes received 1,319,155 options at an exercise price of $42, with the same exercise window; his resulting holdings in this class stand at 3,086,756.
  • All holdings direct: All reported securities are held directly by the reporting person.
  • Filed by attorney-in-fact: The form was signed by Boudien Moerman as attorney-in-fact for Sykes on October 30, 2026.

David Sykes's Reported Transactions in Klarna Ordinary Shares and Options

According to the filing, David Sykes, identified as Chief Commercial Officer of Klarna Group plc (NYSE:KLAR), reported two acquisitions of ordinary shares during the covered period. On July 30, 2026, he acquired 541 shares through an M-coded transaction, bringing his directly held ordinary shares to 181,941. On September 28, 2026, an A-coded transaction added 65,457 shares, lifting the total to 247,398 shares held directly. The filing notes "Not Applicable" as the price explanation for both transactions.

The filing also discloses two option grants, both dated August 20, 2026, each with transaction code A. The first grant covers 341,917 options in Klarna Group plc Ordinary Shares at an exercise price of $14 per share. The second grant covers 1,319,155 options at an exercise price of $42 per share. Both option grants share an identical exercise window: exercisable beginning August 20, 2027, and expiring February 20, 2031. Following these grants, the filing reports Sykes holds 1,767,601 options in the $14 class and 3,086,756 in the $42 class, all directly owned.

The form was filed on October 30, 2026, with Boudien Moerman signing as attorney-in-fact on behalf of Sykes. The earliest transaction date listed in the filing is July 30, 2026. No indirect beneficial ownership is reported for any of the listed securities.

What Was Disclosed

The filing reports two ordinary share acquisitions totaling 66,298 shares acquired by David Sykes between July and September 2026, and two option grants on August 20, 2026, covering a combined 1,661,072 options at exercise prices of $14 and $42, all held directly.